Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil ODT in Men With Erectile Dysfunction
NCT00655629Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Vardenafil ODT with Placebo (2 arms). Primary endpoints: International Index of Erectile Function - Erectile Function Domain at 12 weeks, Sexual Encounter Profile Question 2 at 12 weeks and 1 more. Started Apr 2008; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00655629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655629.